Get the latest Science News and Discoveries

Alzheimer’s drug saga prompts journal to scrutinize whistle-blowers. Publication requires complainants to disclose financial conflicts in the wake of controversy over Cassava Sciences’ experimental treatment simufilam.

None

Related news:

Most humans haven't evolved to cope with the cold, yet we dominate northern climates—here's why

Milky Way’s Stellar Halo is At Least Two Million Light-Years Across

World’s Oldest Meal Helps Unravel Mystery of Our Earliest Animal Ancestors